This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
A Framework for Successful Intrathecal Pain Management: New Insights from the 2017 Polyanalgesic Consensus Conference (PACC) Guidelines

A Framework for Successful Intrathecal Pain Management: New Insights from the 2017 Polyanalgesic Consensus Conference (PACC) Guidelines

Format

Webcast

Time to Complete

1 hour

Released

April 18, 2017

Expires

April 18, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses (includes 1.00 pharmacotherapeutic contact hour)
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider


This educational initiative is provided by CME Outfitters.

Commercial Supporter

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Program Description

Once perceived to be a management approach reserved for salvage therapy—the final straw—after failure of oral high dose opioids, intrathecal drug delivery (IDD) has been established as a cost-effective and efficacious pain management strategy for patients with refractory chronic pain. As the use of IDD expands, there is a need to reduce variability among health care providers in medications that are used, patient selection, trialing, and dosing in order to improve safety and patient outcomes.

In 2000, the Polyanalgesic Consensus Conference (PACC) was formed to provide guidance and recommendations to physicians utilizing IDD to promote safe and effective therapy for patients with refractory chronic pain. As new devices were introduced, new evidence emerged, and experience with intrathecal (IT) therapy expanded—identifying both deficiencies and opportunities—the PACC guidelines were updated. On January 2, 2017, the updated PACC: Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines were released.

Join us for this 60-minute symposium as expert faculty translate the new PACC guidelines for use in clinical practice.

Intended Audience

Pain physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare providers treating patients with chronic pain.

Educational Objectives

At the end of this CME/CE activity, participants should be able to:

  • Translate updates and recommendations in the 2017 PACC guidelines to clinical decision making for patients with refractory chronic pain who are candidates for intrathecal (IT) therapy.
  • Apply PACC recommendations for trialing of appropriate patients who are candidates for IT therapy.
  • Implement dosing and titration strategies in patients utilizing IDD to maximize results while mitigating risks.

The following learning objectives pertain only to those requesting CNE credit:

  • Explain updates and recommendations in the 2017 PACC guidelines for patients with refractory chronic pain who are candidates for intrathecal (IT) therapy.
  • Identify PACC recommendations for trialing of appropriate patients who are candidates for IT therapy.
  • Describe dosing and titration strategies in patients utilizing IDD to maximize results while mitigating risks.

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Gladstone C. McDowell II, MD
Medical Director
Integrated Pain Solutions
Columbus, OH

Dr. McDowell reports that he receives research support from Flowonix Medical Inc.; Jazz Pharmaceuticals; Mallinckrodt Pharmaceuticals; and Medtronic. He serves on the speakers bureau for Jazz Pharmaceuticals and Medtronic. He is a consultant for Flowonix Medical Inc. and Jazz Pharmaceuticals.

Jason E. Pope, MD, DABPM, FIPP
President
Summit Pain Alliance
Santa Rosa, CA

Dr. Pope reports that he receives research support from Abbott; Flowonix Medical Inc.; Jazz Pharmaceuticals; Mesoblast Limited; Nevro Corp.; and Saluda Medical. He is a consultant for Abbott; Flowonix Medical Inc.; Jazz Pharmaceuticals; Medtronic; Nevro Corp.; and Saluda Medical.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Planners' and Managers' Disclosures

Tony Graham, MD, (peer reviewer) has no disclosures to report.
Kimberley Murray, RN, MS, (peer reviewer) has no disclosures to report.
Sharon Tordoff, CHCP, (planning committee) has no disclosures to report.
Jan Perez, CHCP, (planning committee) has no disclosures to report.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

CME Outfitters designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

CME Outfitters, LLC, is approved by the California Board of Registered Nursing.

Designation Statement

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510 for 1.00 contact hour.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.00 contact hour of pharmacotherapeutic contact hours.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.00 contact hour (0.10 CEUs)

Universal Activity Number: 0376-0000-17-007-H01-P

Activity Type: knowledge-based

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)TM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the post-test. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact info@cmeoutfitters.com.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue